跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
WEZENLA 45 MG SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
WEZENLA 45 MG SOLUCION INYECTABLE
Approved
STANDARD
WEZENLA 45 MG SOLUCION INYECTABLE
Amgen Technology (Ireland) Unlimited Company
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 26, 2024
Approval ID
945380c0d7e7ab72
Company
Amgen Technology (Ireland) Unlimited Company
Type
Standard
Approval Details
Approval Id
945380c0d7e7ab72
Drug Cima Aemps Name
WEZENLA 45 MG SOLUCION INYECTABLE
Register Number
1241823001
Holder Company Name
Amgen Technology (Ireland) Unlimited Company
Marketing Company Name
Amgen S.A.
Holder Company Detail Path
/organization/amgen-technology-ireland-unlimited-company
Marketing Company Detail Path
/organization/amgen-sa
Authorization Date
2024-06-26
Dosage Form
SOLUCIÓN INYECTABLE
Dose
45 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Amgen Technology (Ireland) Unlimited Company
Company Detail Path
/organization/amgen-technology-ireland-unlimited-company
Company Information
Pharmaceutical Company Name
AMGEN TECHNOLOGY (IRELAND) UNLIMITED COMPANY
Country Name
Ireland
City Name
dun laoghaire,country_ie
Address
Pottery Road
Active Ingredients
USTEKINUMAB
45 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 26, 2024
Approval ID
945380c0d7e7ab72
Type
Standard
Back to CIMA-AEMPS Approvals